Shattuck Labs, Inc. (STTK)
NASDAQ · Healthcare
$6.82-9.43%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $360.71M
- P/E ratio
- —
- EPS
- —
- Volume
- 1,742,789
- 52-week high
- —
- 52-week low
- —
- Open
- $7.80
- Day high
- $7.80
- Day low
- $6.64
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $1M | -$48.81M | -$0.70 |
| 2024 | $5.72M | -$75.41M | -$1.49 |
| 2023 | $1.66M | -$87.3M | -$2.05 |
| 2022 | $652K | -$101.95M | -$2.41 |
| 2021 | $30.02M | -$44.97M | -$1.07 |
About Shattuck Labs, Inc.
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
- CEO
- Taylor H. Schreiber
- Employees
- 40
- Country
- US
- IPO date
- Oct 9, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Shattuck Labs, Inc.'s stock price today?
- STTK is trading at $6.82 as of Jul 20, 2026.
- What is Shattuck Labs, Inc.'s market cap?
- Shattuck Labs, Inc. (STTK) has a market capitalization of $360.71M.
- Does Shattuck Labs, Inc. pay a dividend?
- Shattuck Labs, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Shattuck Labs, Inc. in?
- Shattuck Labs, Inc. operates in the Healthcare sector.